Codexis Inc - Company Profile
Powered by 
All the sales intelligence you need on Codexis Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Codexis Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Codexis Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Codexis Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Codexis Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Stephen Dilly, Ph.D.
Chairman Executive BoardMr. Stephen Dilly has been the Chairman of the company since 2024. Previously, he served as the Chief Executive Officer and President of the company. Prior to this, he served as the Chief Executive Officer of Sierra Oncology Inc. Mr. Dilly also served as the Chief Executive Officer of Aimmune Therapeutics.
Alison Moore, Ph.D
Director; President; Chief Executive Officer Executive BoardMs. Alison Moore has been the Chief Executive Officer, President, and Director of the company since November 2025. Prior to this, she served as the Chief Technology Officer of the company since 2024. Previously, she served as the Chief Technical Officer and Executive Vice President of Operations at Allogene Therapeutics.
Georgia Erbez
Chief Business Officer; Chief Financial Officer Senior ManagementMs. Georgia Erbez has been the Chief Financial Officer and Chief Business Officer of the company since November 2025. Prior to this, she served as the Chief Operating Officer of Walking Fish Therapeutics. Previously, she served as the Chief Financial Officer of Harpoon Therapeutics. Ms. Erbez also served as the Chief Business Officer and Chief Financial Officer at Zosano Pharma Corp, and Chief Financial Officer for Revolution Medicines, Asterias Biotherapeutics and Raptor Pharmaceuticals.
Stefan Lutz, Ph.D
Chief Scientific Officer Senior ManagementMr. Stefan Lutz has been the Chief Scientific Officer of the company since November 2025. Prior to this, he served as the Senior Vice President, Research of the company. Previously, he served as the Chemistry Department Chair at the Chemistry Department at Emory University.
Karen Frechou-Armijo
Head - Human Resource; Senior Vice President Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer